Skip to main content
Premium Trial:

Request an Annual Quote

Charles River, Proteome Systems to Launch Proteomics Services Business

NEW YORK, April 3 - Charles River Laboratories International and Proteome Systems have opened a new contract laboratory designed for proteomic research services.


The new services, called Charles River Proteomic Services, will offer proteomic research services on a fee-for-service, contract basis to pharmaceutical and biotechnology clients worldwide. A grand opening of the Worcester, Mass., facility will take place April 29.


The service is the product of a joint venture the two companies created last October. The JV operates from Charles River's Discovery and Development Services facility in Worcester, near Proteome Systems' US base in Woburn. Charles River Laboratories maintains an 80 percent ownership in the JV.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.